Cleared Special

K192996 - Selectra Catheters

K192996 is the FDA 510(k) clearance for Selectra Catheters by Biotronik, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Special 510(k) pathway after a 24-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2019
Decision
24d
Days
Class 2
Risk

K192996 is an FDA 510(k) clearance for the Selectra Catheters, Selectra Accessory Kit, Selectra Slitter Tool. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Biotronik, Inc. (Lake Oswego, US). The FDA issued a Cleared decision on November 21, 2019 after a review of 24 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Biotronik, Inc. devices

Submission Details

510(k) Number K192996 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 28, 2019
Decision Date November 21, 2019
Days to Decision 24 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
101d faster than avg
Panel avg: 125d · This submission: 24d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 573
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K192996.
ASAHI CROSSWALK Peripheral Support Catheter
K192782 · Asahi Intecc Co., Ltd. · Nov 2019
AXS Infinity LS Plus Long Sheath
K193034 · Stryker Neurovascular · Nov 2019
PG Pro Microcatheter
K192625 · MicroVention, Inc. A TERUMO Group Company · Nov 2019
CERENOVUS Large Bore Catheter
K191237 · Codman & Shurtleff, Inc. · Nov 2019
087 Balloon Guide Catheter System
K192525 · Q'Apel Medical, LLC · Oct 2019
Medtronic 6F Taiga Guiding Catheter
K192296 · Medtronic Vascular · Sep 2019